[ad_1]
Immunogen IMGN reported its Q2 earnings results on Friday, July 29, 2022 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Immunogen missed estimated earnings by 14.29%, reporting an EPS of $-0.24 versus an estimate of $-0.21.
Revenue was down $2.79 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 4.54% drop in the share price the next day.
Here’s a look at Immunogen’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -1.71 | -0.18 | -0.18 |
| EPS Actual | -0.10 | -0.17 | -0.18 | -0.15 |
| Revenue Estimate | 21.47M | 25.65M | 19.03M | 18.92M |
| Revenue Actual | 38.08M | 27.99M | 9.21M | 16.95M |
To track all earnings releases for Immunogen visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.